Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease

快速眼动睡眠行为障碍 生物标志物 帕金森病 多巴胺转运体 嗅觉减退 内科学 医学 疾病 路易氏体型失智症 肿瘤科 心理学 痴呆 多巴胺 生物 多巴胺能 2019年冠状病毒病(COVID-19) 传染病(医学专业) 生物化学
作者
Shijun Yan,Cheng Jiang,Annette Janzen,Thomas R. Barber,Aline Seger,Michael Sommerauer,Jason J. Davis,Kenneth Marek,Michele Hu,Wolfgang H. Oertel,George K. Tofaris
出处
期刊:JAMA Neurology [American Medical Association]
卷期号:81 (1): 59-59 被引量:17
标识
DOI:10.1001/jamaneurol.2023.4398
摘要

IMPORTANCE Nonmotor symptoms of Parkinson disease (PD) often predate the movement disorder by decades. Currently, there is no blood biomarker to define this prodromal phase. OBJECTIVE To investigate whether α-synuclein in neuronally derived serum-extracellular vesicles identifies individuals at risk of developing PD and related dementia. DESIGN, SETTING, and PARTICIPANTS This retrospective, cross-sectional multicenter study of serum samples included the Oxford Discovery, Marburg, Cologne, and Parkinson’s Progression Markers Initiative cohorts. Participants were recruited from July 2013 through August 2023 and samples were analyzed from April 2022 through September 2023. The derivation group (n = 170) included participants with isolated rapid eye movement sleep behavior disorder (iRBD) and controls. Two validation groups were used: the first (n = 122) included participants with iRBD and controls and the second (n = 263) included nonmanifest GBA1 N409S gene carriers, participants with iRBD or hyposmia, and available dopamine transporter single-photon emission computed tomography, healthy controls, and patients with sporadic PD. Overall the study included 199 participants with iRBD, 20 hyposmic participants with available dopamine transporter single-photon emission computed tomography, 146 nonmanifest GBA1 N409S gene carriers, 21 GBA1 N409S gene carrier patients with PD, 50 patients with sporadic PD, and 140 healthy controls. In the derivation group and validation group 1, participants with polysomnographically confirmed iRBD were included. In the validation group 2, at-risk participants with available Movement Disorder Society prodromal markers and serum samples were included. Among 580 potential participants, 4 were excluded due to alternative diagnoses. EXPOSURES Clinical assessments, imaging, and serum collection. MAIN OUTCOME AND MEASURES L1CAM-positive extracellular vesicles (L1EV) were immunocaptured from serum. α-Synuclein and syntenin-1 were measured by electrochemiluminescence. Area under the receiver operating characteristic (ROC) curve (AUC) with 95% CIs evaluated biomarker performance. Probable prodromal PD was determined using the updated Movement Disorder Society research criteria. Multiple linear regression models assessed the association between L1EV α-synuclein and prodromal markers. RESULTS Among 576 participants included, the mean (SD) age was 64.30 (8.27) years, 394 were male (68.4%), and 182 were female (31.6%). A derived threshold of serum L1EV α-synuclein distinguished participants with iRBD from controls (AUC = 0.91; 95% CI, 0.86-0.96) and those with more than 80% probability of having prodromal PD from participants with less than 5% probability (AUC = 0.80; 95% CI, 0.71-0.89). Subgroup analyses revealed that specific combinations of prodromal markers were associated with increased L1EV α-synuclein levels. Across all cohorts, L1EV α-synuclein differentiated participants with more than 80% probability of having prodromal PD from current and historic healthy control populations (AUC = 0.90; 95% CI, 0.87-0.93), irrespective of initial diagnosis. L1EV α-synuclein was increased in at-risk participants with a positive cerebrospinal fluid seed amplification assay and was above the identified threshold in 80% of cases (n = 40) that phenoconverted to PD or related dementia. CONCLUSIONS AND RELEVANCE L1EV α-synuclein in combination with prodromal markers should be considered in the stratification of those at high risk of developing PD and related Lewy body diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Grace发布了新的文献求助10
刚刚
Hello应助库库的brother采纳,获得10
1秒前
爆米花应助俭朴的明雪采纳,获得10
2秒前
3秒前
所所应助很多奶油采纳,获得10
3秒前
852应助谭天龙采纳,获得10
3秒前
5秒前
wuzhihong完成签到,获得积分10
6秒前
10秒前
上官若男应助GK采纳,获得10
10秒前
我是老大应助zp采纳,获得10
10秒前
11秒前
小杜发布了新的文献求助10
11秒前
13秒前
子车茗应助虚心的静枫采纳,获得10
13秒前
oceanao应助虚心的静枫采纳,获得20
13秒前
orixero应助儒雅无剑采纳,获得10
13秒前
研友_VZG7GZ应助西咪替丁采纳,获得10
14秒前
香蕉觅云应助科研通管家采纳,获得10
14秒前
suofzcn发布了新的文献求助10
14秒前
无花果应助科研通管家采纳,获得10
14秒前
爆米花应助科研通管家采纳,获得30
14秒前
烟花应助科研通管家采纳,获得30
14秒前
Yziii应助科研通管家采纳,获得20
14秒前
华仔应助科研通管家采纳,获得10
14秒前
Hello应助科研通管家采纳,获得10
14秒前
无花果应助科研通管家采纳,获得20
14秒前
雪白问兰应助科研通管家采纳,获得10
14秒前
情怀应助科研通管家采纳,获得30
14秒前
14秒前
15秒前
彭于晏应助科研通管家采纳,获得30
15秒前
科目三应助科研通管家采纳,获得30
15秒前
丘比特应助科研通管家采纳,获得10
15秒前
坦率耳机应助科研通管家采纳,获得150
15秒前
丘比特应助科研通管家采纳,获得30
15秒前
雪白问兰应助科研通管家采纳,获得10
15秒前
Jasper应助科研通管家采纳,获得10
15秒前
SciGPT应助科研通管家采纳,获得10
15秒前
酷波er应助科研通管家采纳,获得30
15秒前
高分求助中
Evolution 10000
ISSN 2159-8274 EISSN 2159-8290 1000
Becoming: An Introduction to Jung's Concept of Individuation 600
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3160183
求助须知:如何正确求助?哪些是违规求助? 2811217
关于积分的说明 7891442
捐赠科研通 2470335
什么是DOI,文献DOI怎么找? 1315418
科研通“疑难数据库(出版商)”最低求助积分说明 630850
版权声明 602038